CONTROVERSIAL ISSUES OF ARTERIAL HYPERTENSION DURING PREGNANCY


Cite item

Full Text

Abstract

There are many inconsistent positions in the approaches to the management of pregnant women with arterial hypertension (AH). Russian multicenter epidemiological studies Medical and diagnostic tactics for pregnant women with arterial hypertension in Russia DIALOGUE and DIALOGUE II have shown that currently there is no single approach to the formulation of the diagnosis and treatment strategy in clinical practice. In pregnancy, choice of drugs is very limited; many drugs with proven efficacy in AH have contraindications for the use in pregnancy and lactation. Based on analysis of recent clinical recommendations of Society of Cardiology of Russian Federation and foreign societies dealing with the problem of AH in pregnancy, the article discusses the controversial issues of management of pregnant women with AH.

References

  1. Многоцентровое эпидемиологическое исследование "Лечебно-диагностическая тактика ведения беременных с артериальной гипертонией в России" "ДИАЛОГ" // Артериальная гипертензия 2008. № 14 (1). С. 27-39.
  2. Оганов Р.Г., Ткачева О.Н. Лечебно-диагностическая тактика ведения беременных с артериальной гипертонией в России: вопросы диагностики и классификации (по результатам многоцентрового исследования "ДИАЛОГ II") // Акушерство и гинекология 2010. № 5. С. 42-8.
  3. Оганов Р.Г., Ткачева О.Н. Лечебно-диагностическая тактика ведения беременных с артериальной гипертонией в России: анализ лечебной тактики (по результатам многоцентрового исследования "ДИАЛОГ II") // Акушерство и гинекология 2010. № 6. С. 30-6.
  4. Стрюк Р.И., Бакалов С.А., Бунин Ю.А. и др. Диагностика и лечение сердечно-сосудистых заболеваний при беременности. Российские рекомендации // Кардиоваскулярная терапия и профилактика 2010. № 9 (6). Прил. 2.
  5. Report of the National High Blood Pressure Education program. Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:1-22.
  6. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Hypertension 2003;42:1206-52.
  7. Lowe SA, Brown MA, Dekker G, et al. Guidelines for the management of hypertension disorders of pregnancy, 2008, Society of Obstetric medicine of Australia and New Zealand. Aust N Z J Obstet Gynaecol 2009;49(3):242-46.
  8. Rath W, Fischer Th, Clockenbusch W. Diagnostik und therapie hypertensiver schwangerschaftserkrankungen. AWMF-Leitlinie Gestose 2008;24:15-18.
  9. Magee LA, Helewa ME, Moutquin JM, et al. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy. This guideline has been reviewed and approved by the Hypertension Guideline Committee and approved by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada. JOGC 2008;48.
  10. Рабочая группа по лечению артериальной гипертонии Европейского общества гипертонии (ESH) и Европейского общества кардиологов (ESC). Рекомендации 2007 года по лечению артериальной гипертонии // Рациональная фармакотерапия в кардиологии 2008. № 2. Прил. 2.
  11. Expert Consensus Document on Management of Cardiovascular Diseases during Pregnancy. Eur Heart J 2003;24(8):761-81.
  12. Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. NICE Clinical Guidelines. London: RCOG Press 2010;107.
  13. Levine RJ. Should the definition of preeclampsia include a rise in diastolic blood pressure >15 mm Hg? Am J Obstet Gynecol 2000;182:225.
  14. North RA, Taylor RS, Schellenberg JC. Evaluation of a definition of pre-eclampsia. Br J Obstet Gynaecol 1999;106:767-73.
  15. Сидорова И.С. Гестоз. М., 2003. 416 с.
  16. Martin JN, Thigpen BD, Moore RC, et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005;105:246-54.
  17. Abalos E, Duley L, Steyn DW, et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2007;(1):CD002252.
  18. Nabhan AF, Elsedawy MM. Tight control of mild-moderate pre-existing or non-proteinuric gestational hypertension. Cochrane Database Syst Rev 2011;(7):CD006907.
  19. Dadelszen P, Ornstein MP, Bull SB, et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000;355:87-92.
  20. Dadelszen P, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. J Obstet Gynaecol Can 2002;24(12):941-5.
  21. Magee LA, von Dadelszen P, Chan S, et al. The CHIPS Pilot Trial (Control of Hypertension In Pregnancy Study). J Obstet Gynaecol Can 2006;28:416.
  22. Cockburn J, Moar VA, Ounsted M, Redman CW. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982;1:647-49.
  23. Podymow T, August Ph. Update on the Use of Antihypertensive Drugs in Pregnancy. Hypertension 2008;51:960-69.
  24. Weber-Schoendorfer C, Hannemann D, Meister R, et al. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study. Reprod Toxicol 2008;26(1):24-30.
  25. Давидович И.М., Блощинская И.А., Петричко Т.А. Артериальная гипертония и беременность: механизмы формирования, эффективность амлодипина (Нормодипина) // РМЖ 2003. № 4. С. 197-200.
  26. Wichman K, Ryulden G, Karberg BE. A placebo-controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scand J Clin Lab Invest 1984;169:90-4.
  27. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ 1990;301:587-9.
  28. Lip GYH, Beevers M, Churchill D, et al. Effect of atenolol on birth weight. Am J Cardiol 1997;79:1436-8.
  29. Lydakis C, Lip GYH, Beevers M, Beevers DG. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999;12:541-7.
  30. Bayliss H, Churchill D, Beevers M, Beevers DG. Anti-hypertensive drugs in pregnancy and fetal growth: evidence for "pharmacological programming" in the first trimester? Hypertens Pregnancy 2002;21:161-74.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies